MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
601.38
-4.44
-0.73%
After Hours: 608.00 +6.62 +1.10% 19:59 07/24 EDT
OPEN
612.07
PREV CLOSE
605.82
HIGH
612.07
LOW
592.80
VOLUME
492.28K
TURNOVER
--
52 WEEK HIGH
677.90
52 WEEK LOW
306.70
MARKET CAP
16.78B
P/E (TTM)
35.28
1D
5D
1M
3M
1Y
5Y
1D
Medpace: Cancellations Are Normalizing
Seeking Alpha · 18h ago
Medpace Holdings Is Maintained at Outperform by Mizuho
Dow Jones · 1d ago
Medpace Holdings Price Target Raised to $665.00/Share From $586.00 by Mizuho
Dow Jones · 1d ago
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665
Benzinga · 1d ago
Medpace Holdings Price Target Raised to $600.00/Share From $400.00 by BMO Capital
Dow Jones · 1d ago
Medpace Holdings Is Maintained at Market Perform by BMO Capital
Dow Jones · 1d ago
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $600
Benzinga · 1d ago
Medpace Holdings Price Target Raised to $609.00/Share From $462.00 by Truist Securities
Dow Jones · 1d ago
More
About MEDP
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.